Center For Scientific Review; Notice of Closed Meetings

2026-13480 — Government Owned Invention Available for License: A Conserved Viral Peptide for Use in Cancer Immunotherapy

The National Cancer Institute has created a special viral peptide that could help prevent and treat a serious liver cancer called HCC. This new discovery might lead to a vaccine or therapy that boosts the immune system to fight cancer better. Researchers and companies interested in developing this treatment can now license the technology, opening doors for faster progress and potential health benefits worldwide.

2026-13479 — Government Owned Invention Available for License: Chimeric VLP Vaccines To Prevent HTLV-1 Infection

The National Cancer Institute has created a new vaccine to stop HTLV-1, a virus that can cause serious diseases like leukemia. Right now, no vaccine exists, so this invention could protect millions, especially in underserved areas. They’re looking for partners to help develop and license this promising vaccine, which could save lives and reduce healthcare costs in the near future.

2026-13244 — The Federal Demonstration Partnership; Phase VIII Notice

The Federal Demonstration Partnership (FDP) is inviting colleges, universities, research groups, and hospitals that get federal research money to join its Phase VIII starting in 2027. This phase will keep testing new ways to make research funding and rules easier and faster. Applications are due by September 15, 2026, with the program running through the end of 2032.

2026-13311 — Center for Scientific Review; Notice of Closed Meetings

The Center for Scientific Review is holding several closed virtual meetings in late July 2026 to review grant applications and contract proposals. These meetings protect private info and trade secrets while deciding who gets funding. Researchers and organizations applying for grants or contracts should watch these dates closely, as funding decisions could impact their projects and budgets.

2026-13337 — Center for Scientific Review; Notice of Closed Meetings

The Center for Scientific Review is holding several closed virtual meetings on July 24, 2026, to review and evaluate important grant applications related to cancer, imaging, eye diseases, and reproductive health. These meetings protect private info and trade secrets, so they’re not open to the public. Researchers and organizations applying for grants should note the dates as these reviews impact funding decisions.

2026-13204 — Proposed Collection; 30-Day Comment Request; NIH Information Collection Forms to Support the Genetic Testing Registry (OD)

The NIH wants your thoughts on updating forms that help track genetic tests in their registry. If you’re involved in genetic testing or research, these changes could affect how you share info. You’ve got until July 30, 2026, to send in your comments—no cost, just your voice to help make things smoother and smarter!

Previous: 2025-20809 — Determination Pursuant to Section 102 of the Illegal Immigration Reform and Immigrant Responsibility Act of 1996, as Amended

The Department of Homeland Security is speeding up the building of barriers and roads along the Texas border by temporarily skipping some usual rules and laws. This move helps stop illegal crossings and keeps the country safer, starting November 25, 2025. It affects border communities and aims to make border security faster and more effective without delay.

Next: 2025-20811 — Center for Scientific Review; Notice of Closed Meetings

The NIH’s Center for Scientific Review is holding a closed virtual meeting on January 7-8, 2026, to review cancer research grant applications. These meetings are private to protect secret ideas and personal info. Researchers applying for grants should note this important review date, but no new costs or changes affect the public.